How to Manage Medication Risks – APhA submits compounding comments to FDA.

26799_graphic_standard_080816Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

How to Manage Medication Risks – APhA submits compounding comments to FDA. – (866) 348-2889

A pharmacist-run healthcare company is showing that medication risk management (MRM), in which pharmacists thoroughly review complex medication regimens for safety) is more effective than medication therapy management (MTM), where medication is reviewed for drug-drug interactions.

So much better, that the company, Tabula Rasa HealthCare, is in the second year of a five-year demonstration project to reduce hospitalization for Medicare patients through MRM.

“In closed healthcare systems under PACE (Program of All-Inclusive Care for the Elderly), we get better than 90% prescriber uptake on our recommendations to reduce hospitalization from adverse drug events [ADEs]. Those recommendations are reducing hospitalizations anywhere from 25% to 50%,” says Calvin Knowlton, PhD, CEO and founder of Tabula Rasa. “Those are the results that prompted CMS to select us as one of five demonstration projections nationwide.”

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Can you use an inhaler after the expiration date? – Drug for nerve pain boosts high for opioid abusers.

14774_PHARMACY BOARD_072216Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Can you use an inhaler after the expiration date? – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

It is usually safe to use an albuterol sulfate inhaler beyond the expiry date listed on the device, although it may not be as effective as it once was.

An albuterol sulfate (Proventil, Ventolin) inhaler provides relief from asthma attacks and asthma symptoms. Most people do not use reliever inhalers every day, so they may be forgotten about and allowed to expire.

However, it is important to note that not all medications are safe or effective after their expiration dates.

Read on to find out more about expired medications and learn how to store and dispose of albuterol sulfate inhalers safely.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Kreps Law Firm Client Reviews Ratings AVVO – Alabama Pharmacy Board Defense Attorney

Kreps Law Firm Client Reviews Ratings AVVO – Alabama Pharmacy Board Defense Attorney

http://bit.ly/KrepsLawFirmReviews (866) 348-2889

*** 34 Attorney Endorsements

*** 10.0 Perfect AVVO Rating

*** 158 + Perfect 5 Star AVVO Client Reviews

Statewide Defense Law Firm. Anywhere in Alabama. We have helped 1,000’s and we can help you too!

www.alabamapharmacistdefenseattorney.com/Pharmacist_Charge_Penalties.html

Call Kreps today to begin the conversation about you! KLF (866) 348-2889

Pharmacy-01-Fb

Posted in Pharmacist | Tagged , , , , , , , , , , , | Comments Off

Hospira Issues Recall of Labetalol Hydrochloride Injection, USP, to the Hospital/Institution Level – APhA submits compounding comments to FDA.

16513-PHARMACY BOARD-standard-041216Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Hospira Issues Recall of Labetalol Hydrochloride Injection, USP, to the Hospital/Institution Level – APhA submits compounding comments to FDA. – (866) 348-2889

Hospira, Inc, a Pfizer company, is recalling three lots of labetalol hydrochloride injection, USP, 100 mg/20 mL vial, and one lot of labetalol hydrochloride injection, USP, Novaplus® to the hospital/institution level due to the discovery of cracks on the rim surface of vials for these lots, which is covered by the stopper and crimp seal. To date, Hospira has not received any reports of adverse events associated with this issue for the affected lots.

Labetalol hydrochloride injection is packaged in a 20 mL multiple dose fliptop vial per carton, packaged in 50 cartons per case. For cartons, the National Drug Code (NDC) is located on the top and front label, and the lot and expiry date are located on the bottom. For individual vials, the NDC, lot, and expiry date are located on the vial label.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Upcoming Webinar Meetings to Discuss Opioid Epidemic and Infectious Diseases – Drug for nerve pain boosts high for opioid abusers.

14738_graphic_standard_070616Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Upcoming Webinar Meetings to Discuss Opioid Epidemic and Infectious Diseases – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

In an effort to continue to explore the relationship between the opioid epidemic and infectious diseases, particularly hepatitis B, hepatitis C, and HIV, the United States Department of Health and Human Services (HHS) Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) is hosting a webinar on March 8, 2018. This webinar is the second part of the Hidden Casualties Webinars: National Partners’ Response to the Opioid Epidemic and Infectious Diseases, and will focus on health policy perspectives. Part one focused on state government perspectives. To register for the second webinar, and to view a recording of the first webinar, visit HHS’ website.

Further, the OHAIDP and the Office on Women’s Health in the HHS Office of the Assistant Secretary for Health funded the National Academies of Sciences, Engineering, and Medicine (National Academies) to explore how the opioid epidemic is changing the epidemiology of HIV, hepatitis, and other infectious diseases. The National Academies will hold a one and a half day public meeting on the infectious disease consequences of the opioid epidemic on March 12 and 13 in Washington, DC. Those who are interested in attending this meeting, Integrating Infectious Disease Considerations with Response to the Opioid Epidemic – A Workshop, can register to participate either in-person or online via webcast.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Opioid Summit Highlights Trump Administration Actions to Combat Opioid Crisis– APhA submits compounding comments to FDA.

7Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Opioid Summit Highlights Trump Administration Actions to Combat Opioid Crisis– APhA submits compounding comments to FDA. – (866) 348-2889

The White House hosted an Opioid Summit to discuss the actions undertaken by President Donald J. Trump’s Administration to combat the opioid epidemic. Individuals who have been affected by the opioid crisis and organizations focused on addiction and recovery were among the attendees at the summit held March 1, 2018.

A panel of President Trump’s cabinet members – including Secretary of Health and Human Services Alex M. Azar II, Secretary of Veterans Affairs David J. Shulkin, MD, and Secretary of the Department of Housing and Urban Development Benjamin S. Carson, Sr, MD – discussed the actions undertaken to provide education, prevention, treatment, and recovery. Secretary of Homeland Security Kirstjen Nielsen and Attorney General Jeff Sessions discussed law enforcement and drug interdiction efforts. These actions and efforts are detailed in a White House fact sheet.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Commissioner Addresses Flu Response and Preparedness Efforts – Drug for nerve pain boosts high for opioid abusers.

6Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

FDA Commissioner Addresses Flu Response and Preparedness Efforts – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

In oral testimony before the US House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, FDA Commissioner Scott Gottlieb, MD, urged immediate steps that can be taken to enhance the product of existing licensed influenza vaccines, and he noted that a universal flu vaccine remains years away.

The testimony was given hearing on US public health preparedness and response efforts to seasonal influenza.

Exploring alternatives to egg-based vaccines is one way to address strain drift or newly emerging strains that make existing vaccines less effective, Dr. Gottlieb said. Many manufacturers are continuing to produce egg-based vaccines, largely because more investment would be needed to fundamentally change manufacturing. Despite this, Dr. Gottlieb indicated that it is worth better understanding the potential of these alternative vaccines.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Daclizumab pulled from market worldwide – APhA submits compounding comments to FDA.

5Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Daclizumab pulled from market worldwide – APhA submits compounding comments to FDA. – (866) 348-2889

Biogen and AbbVie are voluntarily pulling MS treatment daclizumab (Zinbryta) from the market worldwide after several cases of serious inflammatory brain disorders in Germany and Spain were linked to the biologic, including cases of encephalitis and meningoencephalitis. The manufacturers announced the withdrawal on Friday, March 2, the same day the European Medicines Agency (EMA) launched an urgent safety review of daclizumab and declared that it would stop ongoing clinical trials in the European Union.

In a statement, the manufacturers said they believe it would not be possible to characterize the risk-benefit profile of daclizumab because of the limited number of patients who use it. Approximately 8,000 patients have received daclizumab worldwide.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

ACIP’s February meeting focused on influenza, hepatitis, HPV, and more – Drug for nerve pain boosts high for opioid abusers.

14676_graphic_standard_062716Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

ACIP’s February meeting focused on influenza, hepatitis, HPV, and more – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

CDC’s Advisory Committee on Immunization Practices (ACIP) met in Atlanta on February 21–22, 2018, to discuss a variety of immunization topics, including influenza activity and use of the live attenuated influenza vaccine (LAIV) in the upcoming season, hepatitis B and A recommendations, and an update on the human papilloma vaccine (HPV). A summary of these discussions is presented here, and complete meeting minutes will be published on CDC’s website. The next ACIP meeting is scheduled for June 20–21, 2018.

Influenza update
The number of influenza cases is starting to decline for this season, but activity is still widespread. This season marks the highest rate of hospitalizations since 2009. Eighty-nine percent of type A viruses have been the H3N2 strain; however, type B virus cases are increasing. The committee noted that 98% of the H3N2 component was a match to the cell-propagated vaccine, but only 64% matched the egg-propagated vaccine virus. In addition, the B viruses have had minimal drift this year (<1%).

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

New CDC Training Offers CPE on Antibiotic Stewardship – APhA submits compounding comments to FDA.

1806_Graphic-Image_PinteresAlabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

New CDC Training Offers CPE on Antibiotic Stewardship – APhA submits compounding comments to FDA. – (866) 348-2889

The Centers for Disease Control and Prevention’s (CDC’s) Office of Antibiotic Stewardship is offering free continuing education (CE) opportunities for health care professionals. Focused on judicious antibiotic prescribing and antibiotic resistance, the online training is offered in four sections, each with multiple modules. Section 1 of the “CDC Training on Antibiotic Stewardship” is open now, while the additional sections will be released throughout 2018. More information and resources about CDC’s national effort to help fight antibiotic resistance and improve antibiotic prescribing and use are available on its website.

CDC is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This program meets the criteria for 0.258 CEUs of CPE credit. The ACPE Universal Activity Number is 0387-0000-18-031-H05-P.

CLICK HERE FOR CONTINUE READING

 

Posted in Pharmacist | Tagged , , , | Comments Off